Minaris

Silver Sponsor

Minaris Advanced Therapies is the pure‑play cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) business unit of Minaris. With more than 25 years of CGT and viral vectors manufacturing experience, we bring the technical expertise, quality mindset, and global infrastructure required to support programs from early development through commercial manufacturing. We partner closely with innovators to simplify complex processes, strengthen manufacturing performance, and execute with precision. Our focus is clear: reduce turnaround times, lower cost per batch, and help expand patient access to transformative cell and gene therapies worldwide.

website